In addition, no correlation between serum BACE1 activity and serum GFAP and NfL levels was observed in FTD patients, suggesting that neural damage and astrogliosis may not influence the peripheral levels of β-secretase. The gene discussed is GFAP; the disease is frontotemporal dementia.